LORINI, RENATA GIUSEPPINA
 Distribuzione geografica
Continente #
EU - Europa 18.768
Totale 18.768
Nazione #
IT - Italia 18.768
Totale 18.768
Città #
Genova 15.089
Rapallo 2.366
Genoa 1.261
Bordighera 52
Totale 18.768
Nome #
Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. 167
Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. 156
X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism: report on new mutation of the DAX-1 gene in two siblings 155
Phenotype/Genotype Correlation and Cystic Fibrosis Related Diabetes Mellitus (Italian Multicenter Study) 146
Are psychobiological markers strongly correlated with allostatic load in population with autism spectrum disorders (ASD)? 142
13C-mixed triglyceride (13C-MTG) breath-test (BT) in Cystic Fibrosis (CF). 139
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metallo proteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study. 138
No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine 137
Impact of inhaled corticosteroids on the risk of early Pseudomonas Aeruginosa acquisition in cystic fibrosis 134
Combined effects of room air treatment systems and intensive antibiotic therapy. 133
Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies 133
A telemedicine support for diabetes management: the T-IDDM project 131
Younger age at diagnosis of Type 1 diabetes mellitus in children of immigrated families born in Italy. 130
Molecular cytogenetic characterization of the first reported case of an inv dup (4p)(p15.1-pter) with a concomitant 4q35.1-qter deletion and normal parents. 129
Nationwide cross-sectional survey of 3560 children and adolescents with diabetes in Italy. 128
Low total plasma homocysteine concentrations in patients with type 1 diabetes 126
Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height 125
Allergic sensitization and symptoms, body mass index, and respiratory function in children with type 1 diabetes mellitus. 125
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. 125
Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine. 124
Home nebulizer use and bacterial colonization in cystic fibrosis. 123
Diabetes mellitus after kidney transplantation in pediatric recipients 121
The IGF system in a case of Costello syndrome 120
Normal values of first -phase insulin response to intravenous glucose in healthy italian children and adolescents 120
Wolfram syndrome (diabetes insipidus, diabetes, optic atrophy, and deafness): clinical and genetic study. 119
Cerebellar atrophy without cerebellar cortex hyperintensity in infantile neuroaxonal dystrophy (INAD) due to PLA2G6 mutation. 119
Plasma and serum total homocysteine concentrations in paediatric patients, evaluated by high-performance liquid chromatography with fluorescence 119
The genetic abnormality in the beta cell determines the response to an oral glucose load 118
A New SPINK5 Mutation in a Patient with Netherton Syndrome: A Case Report. 118
Inflammation markers, lung function tests and exhaled nitric oxide levels in cystic fibrosis patients. 117
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 117
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: a 5-year follow-up study. 116
May T1 diabetes mellitus protect from asthma? 116
Risk of type 1 diabetes development in children with incidental hyperglycemia: a multicenter Italian study 116
Mild hyperhomocysteinemia: vitamin supplementation or not? 115
Blood Ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study) 115
Organ- and non-organ-specific auto-antibodies in children with hypopituitarism on growth hormone therapy. 115
Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. 115
Anti-CD38 autoimmunity in children with newly diagnosed type 1 diabetes mellitus 114
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an italian Cystic Fibrosis Center 114
High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998 113
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. 113
Discrepancy between sensitization to inhaled allergens and respiratory symptoms in pediatric patients with type 1 diabetes mellitus. 113
Genetic investigation in an Italian child with an unusual association of atrial septal defect, attributable to a new familial GATA4 gene mutation, and neonatal diabetes due to pancreatic agenesis. 27(10):1195-200. 113
Use of continuous subcutaneous insulin infusion since the first weeks of pregnancy in five women with type 1 diabetes mellitus. 113
Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: evidence from a Nationwide Italian Twin Study. 112
Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea. 111
KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. 110
Protocol-based reasoning in diabetic patient management. 110
Absence of sonic hedgehog (Shh) germline mutations in patients with thyroid dysgenesis. 109
Type 1 diabetes and epilepsy: more than a casual association? 109
Hyperglycemia in celiac disease: not always pretype 1 diabetes? 109
A novel hepatocyte nuclear factor-1beta (MODY-5) gene mutation in an Italian family with renal dysfunctions and early-onset diabetes 108
Antimicrobial use and Pseudomonas Aeruginosa susceptibility profile in a cystic fibrosis centre 107
The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults. 107
FùPhenotype-genotype correlation and cystic fibrosis related diabetes (CFRD) 106
Clinical aspects of coeliac disease in children with insulin-dependent diabetes mellitus 105
Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation. 105
Epilepsia partialis continua in type 1 diabetes: evolution into epileptic encephalopathy with continuous spike-waves during slow sleep 105
Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity 105
Antibodies to tissue transglutaminase C in newly diagnosed and long-standing type 1 diabetes Mellitus 104
Wolfram syndrome: new mutations, different phenotype 104
Neuroimaging in Growth hormone deficiency 103
Vitamin D receptor polymorphisms: are they really associated with type 1 diabetes? 103
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. 103
Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects 103
GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections 101
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). 100
The glucagon test in the diagnosis of growth hormone deficiency in children with short stature younger than 6 years. 100
Neonatal diabetes mellitus due to pancreatic agenesis and pervasive developmental disorder 100
Comment on: Clinical application of best practice guidelines for genetic diagnosis of MODY2. 100
Eating disorder in type 1 diabetes can be unmasked by information technology. 100
Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). 100
Identification of novel WFS1 mutations in Italian children with Wolfram syndrome 100
Re: Body mass index and allergic sensitization in children with asthma or type 1 diabetes. 100
Iperstaturalità. 99
Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. 99
Auxological and metabolic study in small for gestational age children during 2 years follow-up. 99
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study. 98
Autoimmunity, HLA, Gm and Km polymorphisms in Turner's syndrome. 98
Association of alleles at polymorphic sites in the osteopontin encoding gene in young type 1 diabetic patients 97
Alcaligenes xylosoxidans ed evoluzione della lesione polmonare in fibrosi cistica. 97
Increased adiposity at diagnosis in younger children with type 1 diabetes does not persist: response to Clarke et al. 97
Deterioration of growth hormone (GH) response and anterior pituitary function in young adults with childhood-onset GH deficiency and ectopic posterior pituitary: a two-year prospective follow-up study 97
Neutrophil myeloperoxidase (MPO) and eosinophil cationic protein (ECP) serum levels during steroid and antibiotic treatment in CF patients. 97
Screening for type 1 diabetes genetic risk in newborns of continental Italy primary prevention (PREVEFIN Study) 96
Endocrine aspects of coeliac disease 95
Folic acid, vitamin B12 and homocysteine levels during fasting and after methionine load in patients wit type 1 diabetes mellitus. 95
High incidence of childhood Type 1 diabetes in Liguria (Italy) from 1989 to 1998 95
Congenital hypothyroidism due to defects of thyroid development and mild increase of TSH at screening: data from the Italian National Registry of infants with congenital hypothyroidism. 95
Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). 93
Pancreatic sufficiency and excellent pulmonary status in CF homozygotes for the R347P mutation. 92
Infiltrative entheropaty in children with gluten sensitization. 92
Strong association between time watching television and blood glucose control in children and adolescents with type 1 diabetes: response to Margeirsdottir et al. 92
Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. 92
Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities 92
Wegener's granulomatosis presenting with life-threatening pulmonary hemorrhage in a boy with type 1 diabetes. 91
Telemedicine in Juvenile Diabetes Care (T-IDDM Project): preliminary results. 91
The ALBA project: an evaluation of needs, management, fears of Italian young patients with type 1 diabetes in a school setting and an evaluation of parents' and teachers' perceptions. 91
Letter Re: Neonatal diabetes mellitus and mutation in the HNF-1beta gene. 90
Totale 11.144
Categoria #
all - tutte 40.864
article - articoli 30.269
book - libri 899
conference - conferenze 8.126
curatela - curatele 0
other - altro 292
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.278
Totale 81.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.001 0 0 0 0 0 0 0 0 0 182 507 312
2019/20205.562 164 155 279 277 469 464 1.090 254 422 964 760 264
2020/2021999 81 95 61 69 67 95 49 86 126 84 84 102
2021/20222.457 24 176 180 348 68 148 160 667 72 258 46 310
2022/20232.776 254 142 50 319 485 581 2 204 472 15 227 25
2023/2024903 60 193 27 100 91 250 30 87 56 9 0 0
Totale 18.782